Ireland
--:--IST
Latest
Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide
Clinical Trials in Brazil / NCT07597005
Recruiting Not applicable

Red Propolis Supplementation as a Strategy in Chronic Kidney Disease

NCT07597005 · tracked via the Priya Life Science Brazil tracker
Sponsor
Universidade Federal Fluminense
Phase
Not applicable
Started
2025-09-30
Last updated
2026-05-19

Condition(s) studied

Kidney DiseaseOxidative StressChronic Kidney DiseaseInflammation

Investigational drug(s) / intervention(s)

Red PropolisPlacebo Control

Red Propolis: Participants will receive 200mg of red propolis capsules per day for two months.

Placebo Control: Participants will receive 200mg of placebo capsules per day for two months.

Study summary

The objective of this study is to evaluate the effects of red propolis on inflammation and oxidative stress in patients with chronic kidney disease on conservative management.

Eligibility

Sex
ALL
Min age
18 Years
Max age
65 Years
Healthy volunteers
No
Inclusion Criteria: * patients with CKD stages 3-5 under conservative management Exclusion Criteria: * pregnant, * lactating, * smoker * patients using antibiotics and antioxidant supplements in the last three months * patients with autoimmune and infectious diseases, * patients with cancer, liver disease, and AIDS

Primary outcome measure(s)

  • Change in inflammatory biomarkers — 8 weeks
    Changes in the IL-6 and TNF-α

Trial sites (1)

FacilityCityRegionStatus
Denise Mafra Rio de Janeiro Rio de Janeiro Recruiting

More Universidade Federal Fluminense trials in Brazil

Effects of Jaboticaba (Plinia Cauliflora) Supplementation in Chronic Kidney Disease Patients Starting soon
Effects of Microencapsulated Propolis and Turmeric in Patients With Chronic Kidney Disease Active, not recruiting
Effects of Brazil Nut Supplementation in Patients With Chronic Kidney Disease Undergoing Conservative Treatment Active, not recruiting
Effects of Royal Jelly Supplementation in Chronic Kidney Disease Recruiting
Prospective Longitudinal Clinical Study for the Evaluation of Peri-implant Tissue and Osseointegration After Rehabilitation With Osseointegrated Implants Enrolling by invitation

Other trials for the same condition

Effects of Microencapsulated Propolis and Turmeric in Patients With Chronic Kidney Disease Active, not recruiting
Low Dose ColchicinE in pAtients With Peripheral Artery DiseasE to Address Residual Vascular Risk Recruiting
Effects of Royal Jelly Supplementation in Chronic Kidney Disease Recruiting
Ginger in the Modulation of Inflammatory Cytokines and Oxidative Stress in Patients With Coronary Artery Disease Starting soon
A Study to Learn More About How Safe the Study Treatment Finerenone is in Long-term Use When Taken With an ACE Inhibitor or Angiotensin Receptor Blocker Over 18 Months of Use in Children and Young Adults From 1 to 18 Years of Age With Chronic Kidney Disease and Proteinuria Recruiting
Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT07597005 on ClinicalTrials.gov ↗ ← All trials in Brazil